Search Results 2611-2620 of 13650 for monoclonal antibody

  1. Safety And Efficacy Of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) In Subjects With Systemic Sclerosis - Mayo Clinic

    Positive test for human immunodeficiency virus, hepatitis C antibody, hepatitis B surface antigen, or evidence of active or chronic tuberculosis at Screening.

  2. mSMART: A clear and simple guide for treating patients with multiple myeloma - Mayo Clinic

    If you've ever wondered what Mayo Clinic would do to treat its multiple myeloma patients, guidelines called mSMART outline Mayo specialists' current ...

  3. GEN1046 In Combination With Anticancer Agents For The Treatment Of Advanced Endometrial Cancer - Mayo Clinic

    - PD-1/PD-L1 antibody within 28 days before the planned first dose of trial treatment. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...

  4. Halting the circle: Comprehensive neurogenetics test panels - Mayo Clinic

    Mayo Clinic's test is a single evaluation that incorporates both antibodies commonly associated with NAM — HMGCR-IgG and SRP-IgG. The detection of SRP-IgG ...

  5. Diphtheria, tetanus, acellular pertussis, polio vaccine (intramuscular route) - Mayo Clinic

    The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given only to children 4 to 6 years ...

  6. Non-Hodgkin lymphoma - Doctors and departments - Mayo Clinic

    nstrom macroglobulinemia, Monoclonal gammopathy of undetermined significance ... Bispecific antibody therapy · Bone marrow biopsy · Bone marrow transplant ...

  7. Diphtheria and tetanus vaccine (intramuscular route) - Mayo Clinic

    The vaccine works by causing the body to produce its own protection (antibodies) against these diseases. This vaccine is given to children 6 weeks of age ...

  8. A Study Of Grapiprant And Pembrolizumab In Patients With Advanced Or Progressive MSS Colorectal Cancer - Mayo Clinic

    History of severe hypersensitivity reactions to chimeric or humanized antibodies. Has received prior systemic anticancer therapy including investigational ...

  9. Clinical trials - Oncology (Medical)

    ... antibodies and the factors that may determine disease progression and treatment response. Spinal Cord Stimulation to Treat Chemotherapy-Induced Peripheral ...

  10. Study Of Sacituzumab Govitecan-hziy And Pembrolizumab Versus Treatment Of Physician's Choice And Pembrolizumab In Patients With Previously Untreated, Locally Advanced Inoperable Or Metastatic Triple-Negative Breast Cancer (ASCENT-04) - Mayo Clinic

    participating in observational studies are eligible. - Have previously received topoisomerase 1 inhibitors or antibody drug conjugates containing a ...